NASDAQ:TLRYTilray Stock Price, Forecast & News

Tilray's stock was trading at $7.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TLRY shares have increased by 13.0% and is now trading at $8.01. View which stocks have been most impacted by Coronavirus.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last year. There are currently 2 sell ratings, 12 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Tilray.

Tilray is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Tilray.

Tilray Inc (NASDAQ:TLRY) released its quarterly earnings results on Monday, May, 11th. The company reported ($1.73) earnings per share for the quarter, missing the consensus estimate of ($0.44) by $1.29. The firm earned $52.20 million during the quarter, compared to analyst estimates of $49.37 million. Tilray had a negative net margin of 241.79% and a negative return on equity of 62.82%. The business's revenue for the quarter was up 127.0% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.27) earnings per share. View Tilray's earnings history.

16 analysts have issued 1 year target prices for Tilray's shares. Their forecasts range from $4.00 to $31.00. On average, they anticipate Tilray's stock price to reach $12.77 in the next twelve months. This suggests a possible upside of 59.5% from the stock's current price. View analysts' price targets for Tilray.

Media headlines about TLRY stock have been trending neutral this week, InfoTrie reports. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tilray earned a news impact score of 0.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an impact on the stock's share price in the near term. View the latest news about Tilray.

Some companies that are related to Tilray include Cronos Group (CRON), USANA Health Sciences (USNA), Aurora Cannabis (ACB), Aphria (APHA), Canopy Rivers (RIV), Chromadex (CDXC), Mediwound (MDWD), Sundial Growers (SNDL), Happiness Biotech Group (HAPP), Natural Alternatives International (NAII), Mannatech (MTEX), Cyanotech (CYAN), True Drinks (TRUU), FitLife Brands (FTLF) and GLG Life Tech (GLGLF). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), Advanced Micro Devices (AMD), Aphria (APHA) and Square (SQ).

(TLRY) raised $135 million in an IPO on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company served as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

Tilray's stock is owned by a number of retail and institutional investors. Top institutional investors include Exane Derivatives (0.01%). Company insiders that own Tilray stock include Brendan Kennedy, Christine StClare, Edward Wood Pastorius Jr, Mark Castaneda and Michael Auerbach. View institutional ownership trends for Tilray.

TLRY stock was purchased by a variety of institutional investors in the last quarter, including Exane Derivatives. Company insiders that have bought Tilray stock in the last two years include Brendan Kennedy, and Edward Wood Pastorius Jr. View insider buying and selling activity for Tilray.

Shares of TLRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TLRY stock can currently be purchased for approximately $8.01.

Tilray has a market capitalization of $1.00 billion and generates $166.98 million in revenue each year. The company earns $-321,170,000.00 in net income (profit) each year or ($1.69) on an earnings per share basis. Tilray employs 1,646 workers across the globe.

The official website for Tilray is www.tilray.com.

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The company can be reached via phone at 206-432-9325.